---
title: "HUIYU PHARMACEUTICAL shareholder Wang Xiaopeng plans to reduce his holdings by no more than 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258687382.md"
description: "According to the Zhitong Finance APP, HUIYU PHARMACEUTICAL announced that the company's shareholder Ms. Wang Xiaopeng intends to reduce her holdings in the company by a total of no more than 12.708 million shares through centralized bidding and block trading, with the total reduction not exceeding 3% of the company's total shares"
datetime: "2025-09-24T11:17:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258687382.md)
  - [en](https://longbridge.com/en/news/258687382.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258687382.md)
---

# HUIYU PHARMACEUTICAL shareholder Wang Xiaopeng plans to reduce his holdings by no more than 3%

According to the Zhitong Finance APP, HUIYU PHARMACEUTICAL (688553.SH) announced that the company's shareholder Ms. Wang Xiaopeng intends to reduce her holdings in the company by a total of no more than 12.708 million shares through centralized bidding and block trading, with the total reduction not exceeding 3% of the company's total shares

### Related Stocks

- [688553.CN](https://longbridge.com/en/quote/688553.CN.md)

## Related News & Research

- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)
- [20:38 ETHyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"](https://longbridge.com/en/news/287135394.md)
- [Trump signs order aimed at preventing illicit financial activity, White House says](https://longbridge.com/en/news/286970478.md)